IP Library Granted Patent US 12,606,593
Granted Patent B2
US 12,606,593 · App. 17/044,910 · Granted Apr 21, 2026

Process for producing a membrane protein

Inventors: Scott Treven Myers (Valby, DK); Torsten Høybye Bak Regueira (Værløse, DK); Lena Maria Than Ellingsgaard (Bjæverskov, DK); Simon Lyngaa Krabbe (Copenhagen, DK)
Assignee: E. & J. Gallo Winery
C07K1/34C07K1/165C07K1/36C07K14/705
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,606,593
App. No.
17/044,910
Granted
Apr 21, 2026
Kind
B2
Abstract

A process for the production of a membrane protein is provided. The process including the steps of: expressing a membrane protein in a host organism present in an aqueous medium, liberating the membrane protein from the host organism, adding a detergent solution to solubilize the membrane protein, recovering a liquid fraction of the solubilized membrane protein, subjecting the liquid fraction to chromatography to bind or retain the membrane protein on a stationary phase, and eluting the stationary phase with an elution buffer to produce the membrane protein. The process can produce relatively large amounts of membrane proteins in an efficient way without compromising the quality of the end product.

Claims (23)

1 . A pilot or industrial scale process for producing a membrane protein comprising the steps of:

a. expressing said membrane protein in a host organism present in an aqueous medium,

b. i) liberating the membrane protein from the host organism by mechanically lysing cells of the host organism to form lysed cell membrane fragments that include the membrane protein and ii) isolating the lysed cell membrane fragments including the membrane protein in the form of a pellet by a first centrifugation,

c. adding a detergent solution to a resuspension of the pellet obtained in b to solubilize the membrane protein to form a solubilized membrane protein,

d. recovering a liquid fraction of the solubilized membrane protein obtained in c as a supernatant by a second centrifugation,

e. subjecting the liquid fraction to chromatography to bind or retain the solubilized membrane protein on a stationary phase, and

f. eluting the protein from the stationary phase to produce the solubilized membrane protein, wherein the first and second centrifugations in steps b and d are each performed at 500 g to 30,000 g and the process does not include ultracentrifugation of the liquid fraction obtained in steps b and d.

2 . The process according to claim 1 , wherein the aqueous medium comprising the host organism of step a is filtered prior to the liberating of the membrane protein from the host organism according to step b through a microfiltration membrane having a pore diameter of 0.5 micrometer or less.

3 . The process according to claim 2 , wherein the host organism is isolated after the aqueous medium comprising the host organism is filtered through the microfiltration membrane and by a third centrifugation of the aqueous medium comprising the host organism to form an isolated host organism.

4 . The process according to claim 3 , wherein the isolated host organism is washed with an isotonic saline solution to dissolve contaminating salts and by a fourth centrifugation of the isotonic saline solution including the isolated host organism to isolate a washed host organism.

5 . The process according to claim 1 , wherein a dilution buffer is added prior to step b.

6 . The process according to claim 1 , wherein a cationic flocculant is added to the solubilized membrane protein that is obtained in c to form a suspension.

7 . The process according to claim 6 , wherein the cationic flocculant is a polyamine compound.

8 . The process according to claim 6 , wherein the cationic flocculant is allowed to react with cell parts of the suspension during agitation to form flocs, wherein the liquid fraction of step d is recovered as the supernatant from an additional centrifugation of the suspension containing the flocs.

9 . The process according to claim 1 , wherein the detergent solution added in c is selected from the group consisting of lauryl dimethylamine N-oxide (LDAO), octyl glucoside (OG), dodecyl maltoside (DDM) and combinations thereof.

10 . The process according to claim 1 , wherein the second centrifugation of step d is performed at 1,000 g to 10,000 g.

11 . The process according to claim 1 , wherein the membrane protein is associated with a first part of an affinity pair and the stationary phase is associated with a second part of the affinity pair.

12 . The process according to claim 11 , wherein the first part of the affinity pair is a histidine tag comprising 8 or more histidine molecules.

13 . The process according to claim 1 , wherein step f includes eluting with an elution buffer which comprises imidazole.

14 . The process according to claim 13 , wherein the stationary phase capable of binding or retaining the solubilized membrane protein is present in a column and the column prior to elution with the elution buffer, is washed with a washing buffer comprising 40% or less of a concentration of imidazole in the elution buffer.

15 . The process according to claim 13 , wherein a concentration of imidazole in the elution buffer is 400 mM or more.

16 . The process according to claim 1 , wherein a cationic flocculant is added to the lysed cell membrane fragments that are obtained in b i) to form a suspension.

17 . The process according to claim 6 , wherein the cationic flocculant is allowed to react with the lysed cell membrane fragments of the suspension during agitation to form flocs of the lysed cell membrane fragments including the membrane protein and the pellet in b ii) is formed by separating the flocs from the suspension by the first centrifugation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2026
From: AQUAPORIN A/S
To: E. & J. GALLO WINERY
Reel/Frame 075361/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2020
From: MYERS, SCOTT TREVEN; REGUEIRA, TORSTEN HOYBYE BAK; ELLINGSGAARD, LENA MARIA THAN; KRABBE, SIMON LYNGAA
To: AQUAPORIN A/S
Reel/Frame 054576/0160 →
Priority Claims (1)
DK PA201870202 · Apr 6, 2018 · national
Continuity (1)
Related Publication 20210147477A1 · May 20, 2021
References Cited (39)
US 5468847A · Heilmann · 1995 [cited by examiner]
US 20080207487A1 · DeFrees · 2008 [cited by examiner]
US 20130338344A1 · Ramasubramanyan · 2013 [cited by examiner]
US 20210147477A1 · Myers et al. · 2021 [cited by applicant]
EP 3774842A1 · 2021 [cited by applicant]
WO 2010146365A1 · 2010 [cited by applicant]
WO 2013043118A1 · 2013 [cited by applicant]
WO 2014108827A1 · 2014 [cited by applicant]
WO 2017137361A1 · 2017 [cited by applicant]
WO 2019193139A1 · 2019 [cited by applicant]
Borgnia et al., “Functional Reconstitution and Characterization of AqpZ, the [cited by examiner]
Hang et al., “High-level production of aquaporin Z in [cited by examiner]
Gomez et al., (“Gomez”, “Flocculation of CHO cells for primary separation of recombinant glycoproteins: Effect on glycosylation profiles”, Biochemical Engineering Journal, 132, 244-254, 2018. (Year: 2018). [cited by examiner]
Japan Patent Office, Notification of Reason for Refusal, Application No. 2020554416, Mailed Oct. 25, 2022, 6 pages, English Translation 6 pages. [cited by applicant]
Intellectual Property Office of Singapore, Written Opinion, Application No. 11202009521Y, Dated Mar. 23, 2022, 7 pages. [cited by applicant]
European Patent Office, Communication pursuant to Article 94(3) EPC, Application No. 19716391.8, mailed Jun. 6, 2023, 5 pages. [cited by applicant]
Intellectual Property India, Examination report under sections 12 & 13 of the Patents Act, 1970 and the Patents Rules, 2003, Application No. 202027047498, Dated Jan. 16, 2023, 7 pages. [cited by applicant]
Borgnia M J et al: “Functional reconstitution and characterization of AqpZ, the [cited by applicant]
Hang et al: “High-level productions of aquaporin Z in [cited by applicant]
Jesper et al: “Interaction between sodium dodecyl sulfate and membrane reconstituted aquaporins: A comparative study of spinach SoPIP1; 1 and [cited by applicant]
Patent Cooperation Treaty, Notification of Transmittal of the International Preliminary Report on Patentability, Application No. PCT/EP2019/058609, Mailed Jun. 5, 2020, 8 Pages. [cited by applicant]
Salt D E et al: “Selective flocculation of cellular contaminants from soluble proteins using polyethyleneimine: A study of several organisms and polymer molecular weights”, Enzyme and Microbial Technology, vol. 17, No. … [cited by applicant]
Wang et al: “One-Step extraction of functional recombiant aquaporin Z from inclusion bodies with optimal detergent”, Protein Expression and Purification., vol. 115, XP055597375, ISSN: 1046-5928, DOI: 10.1016/j.pep.2015.… [cited by applicant]
Gomez et al: “Flocculation of CHO cells for primary separation of recombinant glycoproteins: Effect on glycosylation profiles” Biochemical Engineering Journal, vol. 132, XP055597470, ISSN: 1369-703X, DOI: 10.1016/j.bej.… [cited by applicant]
Canadian Intellectual Property Office, Examination Search Report, Application No. 3,095,674, Dated Oct. 20, 2023, 4 pages. [cited by applicant]
Federal Insitute of Industiral Property, Official Action, Application No. 2020136185, Dated Nov. 16, 2023, 5 pages. [cited by applicant]
State of Israel Ministry of Justice, Notice of Deficiencies, Application No. 277565, mailed Mar. 13, 2024, 3 pages, English Translation 3 pages. [cited by applicant]
Arun K. Mohanty et al, “Membrane protein expression and production: effects of polyhistidine tag length and position”, Protein Expression and Purification 2004, vol. 33, p. 311-325, Issue 2, doi:10.1016/j.pep.2003.10.01… [cited by applicant]
Federal Service for Intellectual Property, Request Substantive Examination, Application No. 2020136185/04(066742), Mailed Aug. 16, 2022, 3 pages. [cited by applicant]
Federal Service for Intellectual Property, Search Report, PCT/EP2019/058609, Date of completion Aug. 16, 2022, 2 pages. [cited by applicant]
The State Intellectual Property Office of People's Republic of China, The First Office Action. Application No. 201980023803.X, mailed Oct. 11, 2023, 10 pages, English Translation, 4 pages. [cited by applicant]
Korean Patent Office, Office Action pertaining to 10-2020-7031915, Dated May 20, 2024, 10 Pages English Translation, 12 Pages. [cited by applicant]
The State Intellectual Property Office of People's Republic of China, Second Office Action, Application No. 201980023803.X, Mailed Aug. 4, 2024, 3 pages. [cited by applicant]
Intellectual Property Office of Singapore, Written Opinion, Application No. 11202009521Y, Mailed Jan. 23, 2025, 6 pages. [cited by applicant]
Sanders et al, “Purifying His6-10-Tagged Membrane Proteins From [cited by applicant]
Japan Patent Office, Notice of Reasons for Refusal, Japanese Patent Application No. 2023-171068, Dated Oct. 15, 2024, 3 Pages. [cited by applicant]
Australian Government IP Australia, Examination report No. 1 for standard patent application, Application No. 2019249933, mailed Jan. 17, 2025, 4 pages. [cited by applicant]
Korean Intellectual Property Office, Notice of Final Rejection, Application No. 10-2020-7031915, mailed Jan. 3, 2025, 4 pages, English Translation 4 pages. [cited by applicant]
The State Intellectual Property Office of People's Republic of China, The Third Office Action, Application No. 201980023803.X, mailed Jan. 1, 2025, 6 pages, English Translation 8 pages. [cited by applicant]